Written by: Dr. Akash Chandawarkar, Board Certified Plastic Surgeon, Mirror Plastic Surgery | Last updated: September 9, 2026
Key Takeaways
- A GLP-1 dosing protocol follows a structured schedule that starts low and increases every four weeks to reach an effective maintenance dose while limiting gastrointestinal side effects.
- Each medication, including semaglutide, tirzepatide, and liraglutide, follows a specific FDA-approved titration schedule that balances tolerability with therapeutic benefit.
- Side effects such as nausea, vomiting, and diarrhea tend to appear during dose increases and often improve with dietary changes, hydration, and slower titration.
- Medical supervision supports safe GLP-1 therapy through personalized dosing, lab monitoring, and ongoing adjustments to the lowest effective maintenance dose.
- Patients who want a physician-designed GLP-1 protocol can schedule a consultation at Mirror Plastic Surgery for lab-informed, concierge-level care.
Why Your GLP-1 Dosing Protocol Matters
GLP-1 medications work best when you follow a careful dosing plan. These medications start at low, sub-therapeutic doses and increase slowly so your gastrointestinal system can adapt. A rushed schedule increases nausea, vomiting, and early discontinuation, while a very slow schedule can delay meaningful results.
Nearly half of patients starting GLP-1 therapy stop within the first year, often because they felt unprepared for dose changes or did not have a physician guiding them through side effects. This guide outlines doctor-reviewed, week-by-week protocols for semaglutide, tirzepatide, and liraglutide, and explains how to handle side effects, missed doses, and injection timing. It also highlights why medical supervision forms the foundation of safe, effective treatment.
Book an appointment to begin your GLP-1 journey with a personalized, lab-informed protocol designed by Dr. Akash Chandawarkar.
How a GLP-1 Dosing Protocol Works
A GLP-1 dosing protocol lays out how you start, increase, and maintain your medication dose over time. Every FDA-approved GLP-1 protocol moves through three phases.
- Starting dose: A low, sub-therapeutic dose, such as 0.25 mg semaglutide, held for four weeks to introduce the medication gently and build gastrointestinal tolerance.
- Titration (escalation): Stepwise dose increases, usually every four weeks, that help your body adjust while you move toward a therapeutically effective range.
- Maintenance dose: The dose where you see benefits such as weight loss and glycemic control with side effects you can tolerate. This dose varies by person and by medication.
Titration matters because GLP-1 medications slow gastric emptying and change appetite signaling. Jumping straight to a full dose would overwhelm your digestive system and trigger severe nausea, vomiting, and diarrhea. The four-week intervals come from clinical trials showing that gradual escalation improves tolerability and lowers discontinuation rates.
Semaglutide Dosing Schedule for Wegovy and Ozempic
Semaglutide is the most commonly prescribed GLP-1 and is available as Wegovy for chronic weight management and Ozempic for type 2 diabetes. Both are once-weekly subcutaneous injections.
| Week | Wegovy Dose (Weight Management) | Ozempic Dose (Type 2 Diabetes) |
|---|---|---|
| 1–4 | 0.25 mg | 0.25 mg |
| 5–8 | 0.5 mg | 0.5 mg |
| 9–12 | 1.0 mg | 1.0 mg |
| 13–16 | 1.7 mg | 2.0 mg |
| 17+ | 2.4 mg (maintenance) | 2.0 mg (maintenance) |
Several clinical notes help you interpret this schedule.
- The 0.25 mg starting dose is non-therapeutic and exists to build tolerance rather than deliver weight loss or glycemic benefit.
- The Wegovy label allows a four-week delay in escalation if gastrointestinal symptoms appear, so a slower schedule remains acceptable.
- 2026 update: The FDA approved Wegovy HD (7.2 mg weekly) in March 2026 for adults who need additional weight loss beyond 2.4 mg. Clinical data showed 18.7% average weight loss at 72 weeks versus 15.6% on 2.4 mg, with higher rates of gastrointestinal side effects and altered skin sensation1.
- Missed dose rule: For Ozempic, take a missed dose within five days of the scheduled day. If more than five days have passed, skip it and resume your regular weekly schedule. For Wegovy, take a missed dose only if the next scheduled dose is more than two days away. Otherwise skip it and resume on the regular day. Never double up.
Tirzepatide Dosing Schedule for Mounjaro and Zepbound
Tirzepatide is a dual GIP and GLP-1 receptor agonist that targets two incretin pathways at once. SURMOUNT-5 data showed tirzepatide produced 20.2% body weight loss versus 13.7% for semaglutide1. It is available as Zepbound for weight management and obstructive sleep apnea and as Mounjaro for type 2 diabetes.
2.5 mg5 mg7.5 mg10 mg12.5 mg15 mg (maximum)
| Week | Dose (Mounjaro / Zepbound) |
|---|---|
| 1–4 | |
| 5–8 | |
| 9–12 | |
| 13–16 | |
| 17–20 | |
| 21+ |
Several key points guide safe tirzepatide use.
- The 2.5 mg starting dose is for treatment initiation only and is not an approved maintenance dose.
- The label instructs prescribers to consider a lower maintenance dose if the current dose is not tolerated. The goal is the lowest effective dose.
- In the SURMOUNT-1 trial, average weight loss reached 15.0% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg over 72 weeks1.
- Missed dose rule: Take a missed dose within four days. If more than four days have passed, skip it and resume your regular schedule. Never inject two doses within three days of each other.
Liraglutide Dosing Schedule for Saxenda and Victoza
Liraglutide differs from semaglutide and tirzepatide because you inject it daily and increase the dose weekly. The following schedule applies to Saxenda for weight management.
0.6 mg daily1.2 mg daily1.8 mg daily2.4 mg daily3.0 mg daily (maintenance)
| Week | Saxenda Dose (Weight Management) |
|---|---|
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5+ |
These clinical notes clarify liraglutide use.
- Victoza for type 2 diabetes follows a similar pattern but caps at 1.8 mg daily, with 0.6 mg for week one, then 1.2 mg, then up to 1.8 mg as needed.
- The 3.0 mg Saxenda dose is the only FDA-approved maintenance dose for weight management. Lower doses serve as titration steps.
- Missed dose rule: If you miss a dose and remember within 12 hours, take it. If more than 12 hours have passed, skip it and take your next dose at the regular time. If more than three days have elapsed, restart at 0.6 mg and re-titrate to reduce gastrointestinal side effects.
Managing Side Effects During Dose Titration
Gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation cause many patients to stop GLP-1 therapy. Nausea affected about 44% of Wegovy users and 28% of Zepbound users at the highest doses in pivotal trials, compared with roughly 8–16% on placebo1. These effects usually stay mild to moderate, cluster after dose increases, and often fade within four to eight weeks as your body adapts1.
Several strategies can make titration easier.
- Eat small, frequent meals: Smaller portions reduce gastric load. Choose bland, low-fat foods such as Greek yogurt, crackers, soup, bananas, rice, and oatmeal.
- Avoid trigger foods: High-fat, fried, spicy, or very sweet foods can worsen nausea during titration.
- Stay hydrated: Sip water, broth, or electrolyte drinks throughout the day. Dehydration is a common pathway to kidney injury on these medications.
- Inject in the evening: Peak nausea often appears six to 24 hours after injection, so evening dosing lets you sleep through the worst period.
- Slow your titration: If side effects disrupt daily life, your physician may hold your current dose for an extra four weeks before increasing it.
- Consider anti-nausea medication: Your doctor may prescribe ondansetron (Zofran) or suggest over-the-counter options for more severe symptoms.
Seek urgent medical care for severe persistent abdominal pain, upper-right abdominal pain with fever or jaundice, inability to keep fluids down for more than 24 hours, or signs of a serious allergic reaction.
Missed Dose Guidelines for Common GLP-1 Medications
Each GLP-1 medication has specific rules for missed doses. Never double a dose to make up for a missed one because that approach raises the risk of severe gastrointestinal side effects.
- Semaglutide (Wegovy / Ozempic): For Ozempic, take a missed dose within five days of the scheduled day. If more than five days have passed, skip it and resume your regular weekly schedule. For Wegovy, take a missed dose only if the next scheduled dose is more than two days away. Otherwise skip it and resume on the regular day.
- Tirzepatide (Mounjaro / Zepbound): Take the missed dose within four days. If more than four days have passed, skip it and resume your regular schedule. Never inject two doses within three days of each other.
- Liraglutide (Saxenda / Victoza): Take the missed dose within 12 hours of your usual time. If more than 12 hours have passed, skip it. If more than three days have elapsed, restart at 0.6 mg and re-titrate.
Practical Tips for Injection Timing, Diet, and Lifestyle
Simple habits around timing, food, and movement can make GLP-1 therapy smoother and more effective.
- Best time for a GLP-1 shot: FDA labels for semaglutide, tirzepatide, and liraglutide state that you can inject at any time of day, with or without food. Consistency matters more than the exact hour. Many patients choose mornings so appetite suppression peaks during meals, while others prefer evenings to sleep through potential nausea.
- Weight loss on 0.25 mg semaglutide: Some patients notice modest appetite changes at this dose, but meaningful weight loss usually requires higher doses1. The starting dose focuses on tolerance building.
- Injection sites: The abdomen, thigh, or upper arm are approved sites for tirzepatide. Rotate sites with each injection to reduce the risk of lipohypertrophy, which can affect absorption. As of January 2026, the Mounjaro and Zepbound labels list the upper arm as a caregiver-administered site rather than a self-injection site.
Why Medical Supervision Matters for GLP-1 Dosing
Unsupervised dosing from online or unregulated sources introduces real risk because no one verifies the product, reviews your labs, or monitors side effects. Nearly half of patients starting GLP-1 therapy discontinue within the first year, often due to poor preparation for dose transitions and lack of physician support.
Medical supervision includes baseline lab panels that assess thyroid, liver, kidney, diabetes markers, and hormone levels. It also includes a personalized titration schedule that may differ from the standard protocol based on your response, along with ongoing adjustments to maintain the lowest effective dose.
At Mirror Plastic Surgery, Dr. Akash Chandawarkar, a Harvard-educated and Johns Hopkins-trained plastic surgeon, personally designs every GLP-1 and peptide protocol based on your labs and physiology. Patients receive direct 24/7 access to Dr. Akash via text, clear instructions for self-administration, and continuous support throughout treatment.
If you are considering GLP-1 therapy, a physician consultation helps you start safely with a protocol tailored to your biology. Book an appointment to discuss whether a medically supervised GLP-1 program fits your goals.
Frequently Asked Questions About GLP-1 Dosing
Maximum Weekly GLP-1 Doses
The maximum FDA-approved weekly dose for the original Wegovy is 2.4 mg, and Wegovy HD at 7.2 mg weekly received approval in March 2026. For Ozempic, the maximum is 2.0 mg weekly. For tirzepatide, the maximum is 15 mg weekly for both Mounjaro and Zepbound. Liraglutide is taken daily, with a maximum of 3.0 mg for Saxenda or 1.8 mg for Victoza. Your maintenance dose should remain the lowest dose that provides adequate benefit with tolerable side effects.
Standard GLP-1 Titration Schedules
All FDA-approved GLP-1 protocols begin at a low dose and increase in steps. Weekly injectables such as semaglutide and tirzepatide increase every four weeks. Daily liraglutide increases weekly over five weeks. The standard Wegovy schedule moves from 0.25 mg to 0.5 mg, 1.0 mg, and 1.7 mg before reaching 2.4 mg at week 17. Tirzepatide steps from 2.5 mg to 5 mg, 7.5 mg, 10 mg, and 12.5 mg before reaching 15 mg at week 21. Your physician may extend any interval if you experience significant side effects.
Long-Term Safety of GLP-1 Therapy
Clinical trials support GLP-1 use for at least two to four years. The SELECT trial, the longest randomized follow-up for semaglutide, followed 17,604 adults and showed sustained weight reduction at four years1. The 2026 ADA Standards of Care describe obesity as a chronic disease that often requires ongoing therapy. Weight regain after stopping GLP-1 therapy appears frequently in trials, and many patients regain a large portion of lost weight within one year of discontinuation1. Most patients therefore remain on a long-term maintenance dose, chosen at the lowest level that maintains results.
Switching Between GLP-1 Medications
Switching between GLP-1 medications can work well when a physician manages the transition. Most switches start at the new medication’s lowest dose and follow its titration schedule, although exceptions exist, such as direct switching between semaglutide formulations for patients who tolerated prior therapy. Your physician will design a transition plan based on your response, tolerability, and goals.
Role of Diet and Exercise With GLP-1 Therapy
Diet and exercise remain essential while you take a GLP-1. Semaglutide, tirzepatide, and liraglutide all carry FDA approval alongside a reduced-calorie diet and increased physical activity. These medications amplify lifestyle efforts rather than replace them. Protein intake of about 1.2–1.6 grams per kilogram of body weight and regular resistance training support lean muscle preservation during weight loss.
Next Steps for Safe, Effective GLP-1 Therapy
GLP-1 dosing protocols follow standardized steps that protect you from side effects and help your body adapt, yet your ideal protocol still requires personalization. Generic charts and online advice cannot reflect your labs, medical history, or individual response. Medical supervision provides the structure that keeps GLP-1 therapy both safe and effective.
Mirror Plastic Surgery offers concierge-level care that extends beyond a prescription, including comprehensive lab analysis, a protocol tailored to your physiology, and 24/7 access to your physician. From inflammation and autoimmune conditions to weight management and anti-aging, Mirror Plastic Surgery provides advanced peptide therapies for a wide range of health and wellness needs. Book an appointment to explore how a tailored peptide or GLP-1 protocol can support your goals.
This article is for educational purposes and does not replace medical advice. Always consult a licensed physician before starting any medication. All dosing information has been verified against FDA labels as of September 2026.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
